TL;DR
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
MedPage Today’s Oct. 11, 2026, “What We Heard This Week” roundup collected eight health-related comments from clinicians and health leaders. The remarks addressed unapproved herpes products sold on Amazon, the federal response to measles, nursing candidates for Congress, infection prevention and several early research findings.
MedPage Today published eight health-care quotes in its Oct. 11, 2026, weekly roundup, “What We Heard This Week,” including criticism of unapproved herpes products sold on Amazon and the federal response to a U.S. measles outbreak. The comments also touched on nurses running for Congress, infection prevention, vaping exposure among children with asthma, a rare fungal infection and early findings from small studies.
The roundup’s headline quote came from Jeffrey Klausner, MD, MPH, of Herpes Cure Advocacy, who said, “The public should not be subject to these quack medicines.” He was responding to news that the Food and Drug Administration had warned Amazon over the sale of unapproved herpes treatments. The roundup did not provide details of the agency’s warning or Amazon’s response.
Jeanne Marrazzo, MD, MPH, a former director of the National Institute of Allergy and Infectious Diseases, called the federal government’s response to the U.S. measles outbreak “extremely underwhelming and frankly shameful.” The collection also cited 18 nurses running for Congress in the current election. Jennifer Mensik Kennedy, president of the American Nurses Association, said, “Look at the number of lawyers in office. We should have more nurses.”
Other comments addressed hospital efforts to avoid unnecessary catheter placement and shorten catheter use, children with asthma exposed to vaping and combustible tobacco, and a spike in a rare, potentially deadly fungal infection. The final two quotes concerned research: a small study of radiosurgical capsulotomy for treatment-resistant depression and suicidal ideation, and a study exploring optogenetic therapy for advanced retinitis pigmentosa.
From Product Warnings to Patient Safety
The roundup brings together separate developments that can affect consumer safety, public health and clinical care. Klausner’s criticism reflects concern over unapproved treatments being sold to the public, while the measles comment highlights disagreement over the adequacy of the government’s response to an outbreak. Both statements are attributed opinions, not independent findings established by the quote collection.
The other remarks point to practical questions for health services and patients: how hospitals limit avoidable catheter use, whether clinicians ask about vaping in children’s homes, and how unusual infections are identified outside familiar high-risk groups. The research comments also underline the distance between promising early results and proven care. The source describes the depression study as small and presents the optogenetic work as a study, not as established treatment.
Top picks for "public should subject"
As an affiliate, we earn on qualifying purchases.
The Stories Behind the Quotes
MedPage Today describes the item as a weekly collection of quotes heard by its reporters. The Oct. 11 report groups remarks tied to different coverage rather than presenting one investigation or a single policy announcement. The quotes therefore provide a snapshot of topics its newsroom covered that week, not a unified assessment of U.S. health care.
Several comments refer to developments without supplying the underlying reports. The article’s supplied text does not give the FDA warning’s date or terms, details of the measles outbreak, the methods and results of the catheter or vaping studies, or data on the fungal infection. It also gives no sample size or outcome figures for the two research studies. Those limits matter when interpreting pointed statements or preliminary findings.
““The public should not be subject to these quack medicines.””
— Jeffrey Klausner, MD, MPH, of Herpes Cure Advocacy
Details Behind the Claims and Studies
The roundup does not supply enough detail to independently evaluate the FDA warning, the measles response or the studies referenced in the quotes. It does not state what products Amazon was warned about, what corrective steps the agency sought, or whether the company responded. Nor does it identify the measures used to judge the federal response to measles.
For the research references, the roundup gives no study authors, publication details, participant numbers or full results beyond describing the depression findings as dramatic and the study as small. The infection comment identifies a spike but does not provide a count, location, time period or comparison baseline. The quoted remarks should not be read as proof that a treatment works, that a trend has a particular scale, or that a policy response succeeded or failed.
Follow-Up on Warnings and Research
The source does not announce a specific next event or deadline. Follow-up reporting would need to establish what the FDA required of Amazon and whether the retailer or product sellers changed their listings. More detail on the measles response and outbreak would help readers assess Marrazzo’s criticism against confirmed actions and public-health data.
The studies cited in the roundup will require examination of their full methods and findings before readers can judge their implications. In particular, the small radiosurgical capsulotomy study and the optogenetic research should be understood as research developments, not confirmation that either approach is an available, effective treatment. MedPage Today’s roundup identifies the topics, but it does not say when additional findings or reporting are expected.
Key Questions
What did MedPage Today publish?
It published an eight-quote weekly roundup on Oct. 11, 2026, collecting comments connected to health news and studies covered by its reporters.
Why did Jeffrey Klausner criticize Amazon?
Klausner was responding to news that the FDA warned Amazon for selling unapproved herpes treatments. The supplied roundup does not give the warning’s details or Amazon’s response.
Did the roundup establish that the research treatments work?
No. The radiosurgical capsulotomy findings were described as coming from a small study, and the roundup did not provide full results. The optogenetic therapy was also described as research, not confirmed treatment.
What information is still missing?
The roundup omits details including the FDA warning’s terms, the government actions taken on measles, data behind the infection comment and the methods and results of the studies. The scale and comparison basis for the reported fungal-infection spike are also unspecified.
Source: rss
Evergreen bestsellers Picks
bestsellers
As an affiliate, we earn on qualifying purchases.
